{
    "2018-12-15": [
        [
            {
                "time": "",
                "original_text": "复宏汉霖赴港IPO：4种单抗正在进行3期临床试验",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "IPO",
                        "单抗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "陈光明专户产品备案规模逾80亿 新基金相中哪些上市公司？",
                "features": {
                    "keywords": [
                        "陈光明",
                        "专户产品",
                        "备案规模",
                        "新基金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "资产管理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星上市公司矩阵扩营 复星旅文在港敲钟",
                "features": {
                    "keywords": [
                        "复星",
                        "上市公司",
                        "复星旅文",
                        "IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "旅游",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "带量采购对医药行业 是寒冬还是机遇？",
                "features": {
                    "keywords": [
                        "带量采购",
                        "医药行业",
                        "政策影响"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "政策"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}